U.S. Physical Therapy, Inc. USPH
Set alert
84.90 USD -0.93 -1.08%
At close · Nov 2
84.90 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
84.26 Day range 86.61
58.19 52-week range 90.94
- YTD
- +8.72%
- 1 year
- -1.59%
- Open
- 86.40
- Prev close
- 85.83
- Mkt cap
- 1.27B
- Vol
- 334.71K
- Avg vol
- 180.00K
- EPS
- 0.18
- P/E
- 471.67
- Div yield
- 2.13%
More statistics
- Low
- 84.26
- High
- 86.61
- Forward P/E
- 25.51
- Beta
- 1.13
- Short ratio
- 6.28
- Inst. own
- 112.62%
- Dividend
- 1.84
- Ex-div date
- Aug 20, 2026
- Earnings
- Nov 4, 2026
- 50-d avg
- 82.82
- 200-d avg
- 76.75
- 1y target
- 97.83
3M chart
Events in this range
- Aug 5, 2026Earnings: 0.75; estimate 0.814; surprise -7.86%
- Aug 10, 2026Rating: Barrington Research · Outperform → Outperform
- Aug 21, 2026Dividend: 0.46
- Sep 11, 2026Rating: JP Morgan · Overweight → Overweight
Signals (15)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 2026 | 20 hours ago |
| MACD: Sell Signal | Oct 28, 2026 | 5 days ago |
| MACD: Buy Signal | Oct 22, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 5, 2026 | 4 weeks ago |
| RSI: Overbought | Sep 28, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 15, 2026 | 1 month ago |
| SMA: Bullish | Sep 14, 2026 | 1 month ago |
| SMA: Bearish | Sep 8, 2026 | 1 month ago |
| SMA: Bullish | Sep 4, 2026 | 1 month ago |
| SMA: Bearish | Aug 31, 2026 | 2 months ago |
| SMA: Bullish | Aug 26, 2026 | 2 months ago |
| SMA: Bearish | Aug 24, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 17, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 10, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 5, 2026 | 2 months ago |
Financial health
Altman Z-Score
2.67 Grey zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
5 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 3
Valuation
P/E 55.0×
FY 2016 5y median 48.2× FY 2025
P/S 1.5×
FY 2016 5y median 2.0× FY 2025
P/B 2.5×
FY 2016 5y median 2.8× FY 2025
P/FCF 19.4×
FY 2016 5y median 19.4× FY 2025
EV/EBITDA 14.4×
FY 2016 5y median 17.3× FY 2025
EV/Sales 2.0×
FY 2016 5y median 2.4× FY 2025
FCF Yield 5.1%
FY 2016 5y median 5.1% FY 2025
Profitability
Gross Margin 20.1%
FY 2016 5y median 20.1% FY 2025
Operating Margin 10.3%
FY 2016 5y median 10.3% FY 2025
Net Margin 1.9%
FY 2016 5y median 3.9% FY 2025
ROE 3.2%
FY 2016 5y median 5.4% FY 2025
ROIC 5.4%
FY 2016 5y median 5.4% FY 2025
ROA 1.3%
FY 2016 5y median 2.3% FY 2025
Growth (YoY)
Revenue 16.3%
FY 2016 FY 2025
Operating Income 27.2%
FY 2016 FY 2025
EPS (diluted) -22.8%
FY 2016 FY 2025
Free Cash Flow -7.2%
FY 2016 FY 2025
Financial Health
Current Ratio 1.0×
FY 2016 5y median 1.2× FY 2025
Quick Ratio 1.0×
FY 2016 5y median 1.2× FY 2025
Debt / Equity 0.9×
FY 2016 5y median 0.8× FY 2025
Net Debt / EBITDA 3.6×
FY 2016 5y median 2.9× FY 2025
Interest Coverage 8.5×
FY 2016 5y median 8.5× FY 2025
Dividends
Dividend Yield 2.3%
FY 2016 5y median 2.0% FY 2025
Payout Ratio 181.7%
FY 2016 5y median 100.3% FY 2025
Annual · latest fiscal year ends 2025-12-31
